700 patients110,866 observations180 daysLIVE
← Patients

Patient P-02603

Synthetic patientMETA-24 · Day 130 · 65–74 · F · baseline S14Steering view · 3DOpen companion preview
Therapy response
Unstable
Tolerance
Improving
GI state
Deteriorating
Inflammatory state
Favorable
Nutritional resilience
Favorable
Discontinuation risk
30%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 started — Baseline state S14
  2. Day 28 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 28.

Primary contributors, last 14 days
  • Toxicity-21
  • GI instability+7
  • Treatment adherence+4
  • Inflammatory activity-3
  • Nutritional resilience-3

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Active minutes
    Wearable
    51 min
    worsening · -2.0 vs previous 14 d
    Sleep duration
    Wearable
    8.3 h
    stable · -0.0 vs previous 14 d
    Energy level
    Daily log
    6.2/10
    stable · -0.2 vs previous 14 d
    Steps
    Wearable
    4,719
    worsening · -239 vs previous 14 d
    GI burden
    Companion
    15.3/100
    worsening · +4.0 vs previous 14 d
    Adherence
    Companion
    84.3 %
    improving · +3.4 vs previous 14 d
    Sleep quality
    Wearable
    67.1/100
    stable · -1.1 vs previous 14 d
    Glucose, CGM daily mean
    CGM
    115 mg/dL
    stable · +1.5 vs previous 14 d
    This trajectory is decaying — what would help, what would not
    Steering view →

    Heading towards failing · 72 from the failing basin, 63 from restoration.

    Would help
    • No untried action with strong evidence. Compose one from primitives.
    • More protein
      GI -4.7 next day on high-intake days · n 21
    Would not help
    • BR-03 Behavioural Recommendation
      only 30% improved among 10 similar
    • Keep ultra-processed low
      GI +4.5 next day on high-intake days · n 19
    • Keep alcohol low
      GI +4.4 next day on high-intake days · n 18
    • Keep simple carbs low
      GI +4.2 next day on high-intake days · n 16
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -4.7supporter · 95%
    • Ultra-processed food
      +4.5detractor · 95%
    • Alcohol
      +4.4detractor · 95%
    • Simple carbohydrates
      +4.2detractor · 95%
    • Caffeine
      +2no signal · 48%
    • Insoluble fibre
      -0.6no signal · 15%
    • Dietary fat load
      -0.3no signal · 15%
    • Histamine load
      +0.2no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Inflammatory signalling ↓35
      • MicrobiomeBacteroides fragilis expansion
      • WearableHRV 38 ms, trending down
    • Autonomic recovery ↑25
      • WearableResting HR 73 bpm
    DNA
    Fictional pharmacogenomic panel
    • CYP2D6 Normal metabolizer
      Expected exposure
    • GLP1R rs6923761 A
      Altered receptor sensitivity
    • MTHFR C677T
      Reduced folate turnover
    Microbiome
    Shannon diversity 2.8 · butyrate capacity 64/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisHigh
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    36 ms
    Sleep
    7.9 h
    Steps
    4,288
    Resting HR
    72 bpm
    Daily log: GI score 15, nutritional resilience 66, adherence 84.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Keep fibre steady; no new sources this week
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Log the daily check-in; one line is enough
    • A 15-minute walk after lunch
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0265823%S04——66
    P-0209523%S08——66
    P-0254023%S06——64
    P-0237123%S16——64
    P-0256123%S19——63
    P-0205024%S04——63
    P-0223823%S18——63
    P-0262924%S08——63
    P-0240623%S11——63
    P-0242123%S04——63
    P-0204924%S14——63
    P-0239623%S06——62